
Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus. Since the coronavirus enters the lungs through the nasal passage, the spray could halt the infection in its tracks.
More Stories
Despite promises of solidarity on Covid-19, rich countries are snapping up the supply of promising vaccines
Historic U.S. COVID vaccine campaign launches with convoy of trucks
Brazil rolls out COVID-19 vaccination plan